advertisement
Clinical Ophthalmology 8
Showing records 1 to 8 | Display all abstracts in Clinical Ophthalmology56670 Spontaneous simultaneous bilateral malignant glaucoma of a patient with no antecedent history of medical or surgical eye diseases
Jarade EF; Dirani A; Jabbour E; Antoun J; Tomey KF
Clinical Ophthalmology 2014; 8: 1047-1050
56656 Managing adverse effects of glaucoma medications
Inoue K
Clinical Ophthalmology 2014; 8: 903-913
56669 An observational study of bimatoprost 0.01% in patients on prior intraocular pressure-lowering therapy: the Canadian Lumigan(®) RC Early Analysis Review (CLEAR) trial
Crichton AC; Nixon DR; Simonyi S; Bhogal M; Sigouin CS; Discepola MJ; Hutnik CM; Baptiste DC; Yan DB
Clinical Ophthalmology 2014; 8: 1031-1038
56655 An emerging treatment option for glaucoma: Rho kinase inhibitors
Wang SK; Chang RT
Clinical Ophthalmology 2014; 8: 883-890
56652 Patient adherence and persistence with topical ocular hypotensive therapy in real-world practice: a comparison of bimatoprost 0.01% and travoprost Z 0.004% ophthalmic solutions
Campbell JH; Schwartz GF; LaBounty B; Kowalski JW; Patel VD
Clinical Ophthalmology 2014; 8: 927-935
56643 Prospective unmasked randomized evaluation of the iStent inject (®) versus two ocular hypotensive agents in patients with primary open-angle glaucoma
Fea AM; Belda JI; Rękas M; Jünemann A; Chang L; Pablo L; Voskanyan L; Katz LJ
Clinical Ophthalmology 2014; 8: 875-882
56636 Improving patient outcomes following glaucoma surgery: state of the art and future perspectives
Van Bergen T; Van de Velde S; Vandewalle E; Moons L; Stalmans I
Clinical Ophthalmology 2014; 8: 857-867
56653 Fornix-based versus limbal-based conjunctival flaps in trabeculectomy with mitomycin C in high-risk patients
Kuroda U; Inoue T; Awai-Kasaoka N; Shobayashi K; Kojima S; Tanihara H
Clinical Ophthalmology 2014; 8: 949-954
